SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending after announcing record-high vehicle deliveries for December and the fourth quarter, significantly surpassing previous figures and nearing one million cumulative vehicles. This strong performance, further supported by extended EV subsidies in China, is driving considerable community discussion and optimism about the company's path to profitability and its competitive standing in the electric vehicle market.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions Inc. is trending following news of a strategic manufacturing partnership set to scale production of its drug screening reader for anticipated U.S. market entry. The community is actively discussing the stock's massive volume and micro-float, fueling excitement for potential short-squeeze-like parabolic gains. However, a recent private placement with lower-priced warrants has sparked debate among traders, creating a highly volatile environment with divided opinions on its immediate future.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

SMCX is currently trending amidst significant investor confusion and frustration surrounding a recent dividend event and persistent tracking discrepancies with its underlying asset, SMCI. The community is actively questioning the ETF's unusual behavior, with some alleging it's a "scam" or facing an imminent reverse split, while others view the current downturn as a potential buying opportunity despite concerns about leveraged product decay.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is currently a hot topic, with community discussion centering on the ongoing delay and mixed initial data for its inhaled cystic fibrosis therapy, ARCT-032, which showed some mucus plug reduction but not significant lung function improvements. Investors are closely monitoring an active trade secret lawsuit against AbbVie, generating widespread hope for a substantial settlement or potential acquisition. Many believe the company's advanced mRNA platform and solid cash runway make the stock deeply undervalued amidst significant short interest.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP Crypto is trending after a recent price surge ignited a polarized community discussion. Supporters emphasize its real-world utility through Flexa's merchant network and anticipate significant growth with pending regulatory clarity and strategic partnerships. However, many investors express deep frustration, warning of sustained manipulation and a history of pump-and-dump cycles despite its technological foundations.

SpaceX engineers reusable launch vehicles and the Starlink satellite constellation for global broadband. Their focus on rapid reusability and vertical integration drives down launch costs and accelerates space access.

SpaceX PreStocks

SpaceX is trending due to widespread anticipation of a potential IPO in 2026, which is igniting significant speculative interest across the broader aerospace sector. Community discussions are heavily focused on identifying "SpaceX IPO plays," with companies like Momentus ($MNTS) gaining traction for its partnership on Falcon 9 missions and a notably low share count, sparking comparisons to past explosive meme stock surges.

Grayscale Investments LLC - Grayscale Bitcoin Trust

Grayscale Bitcoin Trust

Grayscale Bitcoin Trust (GBTC) is trending amidst a fervent debate over Bitcoin's near-term price direction, with discussions highlighting recent ETF outflows and broader market dynamics. The community remains sharply divided, as many anticipate a "parabolic" rally for Bitcoin as a hedge against inflation, while others warn of an impending "crypto winter" and significant price corrections based on historical cycles and perceived lack of intrinsic value.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending amid intense community discussion following recent developments, including a partial summary judgment in its ongoing litigation and strategic changes to its executive team, which are fueling heightened speculation around a potential acquisition. Investors are closely monitoring progress for its rare disease therapy, MIPLYFFA, toward European market access and a patent term extension, while broadly criticizing management for perceived undervaluation and executive compensation. Despite these concerns, many maintain a bullish outlook, citing the company's significant cash reserves and pipeline assets as indicators of untapped value.

iShares Ethereum Trust (The) - Undivided Beneficial Interest

iShares Ethereum Trust ETF

iShares Ethereum Trust ETF ($ETHA) is trending amidst strong speculation surrounding spot Ethereum ETF approvals, particularly those offering staking, which is expected to drive institutional demand. The recent "Fusaka Upgrade" is also a key talking point, with its impact on Ethereum's burn rate fueling bullish outlooks and active options trading. While many investors are actively 'buying the dip' and positioning for a potential decoupling from Bitcoin, others maintain caution regarding crypto market volatility.

Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include Cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma, and Remlarsen and MRG-229, which are made for the treatment of patients with pathological fibrosis. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is generating significant buzz after the FDA accepted its Biologics License Application for Veligrotug, granting Priority Review for Thyroid Eye Disease and setting a PDUFA target. The community is widely discussing Veligrotug's potential as a best-in-class treatment, citing its strong efficacy across both active and chronic TED compared to current therapies, which fuels analyst upgrades and M&A speculation for the company's innovative pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

US-China Trade Tension Escalates: Should You Seek Refuge in UK ETFs?

Escalating U.S.-China trade tensions are shaking global markets, prompting investors to eye UK ETFs like EWU as a potential safe haven.   


Should Investors Increase Their Allocation to U.K. ETFs Now?

The U.K. sees mixed signals: slowing growth and easing inflation, but a $150B U.S. deal could spark investor optimism.

The UK has reportedly asked U.S. negotiators to modify domestic-production requirements, which are hindering an agreement to reduce tariffs on British steel exports.According to a Bloomberg News report, citing people with knowledge of the negotiations, the UK has requested that steel imports from European countries, such as the Netherlands, which are subsequently used to manufacture steel products in the UK, be considered British for the purposes of U.S. tariffs.The <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-07-17/uk-pushes-us-to-drop-key-sticking-point-to-steel-trade-deal">report</a> added that the change will exempt products made by Tata Steel UK, which no longer operates a furnace in the UK and imports raw steel from other countries, from U.S. tariffs. U.S. negotiators are reportedly considering such an exemption, as long as steel from countries seen by President Donald Trump as strategic rivals isn’t covered under the UK deal.The U.S. has previously insisted that steel must be melted and poured in the UK to be considered British for tariff purposes, a criterion that Tata Steel, one of the country’s top producers, cannot fulfill.Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/EWU">iShares MSCI United Kingdom ETF</a> (EWU) was in the ‘neutral’ territory at the time of writing.The Bloomberg report added that the trade agreement could be reached soon. Trump had said earlier this week that he expects to refine the trade deal with the UK during his official visit in September.The deal could help UK Prime Minister Keir Starmer’s government, which faced criticism from opposition parties after the initial trade deal with the U.S. in May. While the UK was the first country to announce a framework for a trade agreement, several issues, including steel tariffs, were unresolved.Trump wanted the UK to accept more beef and U.S. ethanol, while London wanted exemptions for cars and steel products. U.S. tariffs on UK steel products remain at 25% as the country was exempted from a June hike of tariffs to 50%.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/japan-exports-slip-again-in-june-as-trump-tariffs-bite-with-doubts-over-trade-deal/ch8KJMfR5YB">Japan Exports Slip Again In June As Trump Tariffs Bite, With Doubts Over Trade Deal</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Steel materials gather in the warehouse of Lianyungang Port, waiting to be loaded onto ships in Lianyungang City, Jiangsu Province, China, on June 1, 2025. (Photo by Costfoto/NurPhoto via Getty Images)

 UK Reportedly Urges Trump Administration To Relax Import Rules Hindering Steel Trade Deal

The UK has requested that steel imports from European countries, such as the Netherlands, which are subsequently used to manufacture steel products in the UK, be considered British for the purposes of U.S. tariffs.

 UK Reportedly Urges US To Relax Import Rules Hindering Steel Trade Deal

Equity

The UK has requested that steel imports from European countries, such as the Netherlands, which are subsequently used to manufacture steel products in the UK, be considered British for the purposes of U.S. tariffs.


Citi’s Willer expects AI trade to outweigh Middle East risks

Investing.com -- Citi’s Global Head of Macro and Asset Allocation maintains a constructive stance on equities despite ongoing geopolitical tensions in the Middle East, highlighting a renewed focus on the AI trade as a key driver of market sentiment.

UK exports to the U.S. saw the sharpest drop on record in April as U.S. President Donald Trump’s tariffs upended global trade.According to the Office for National Statistics data, Britain shipped 4.1 billion pounds ($5.6 billion) worth of goods to its North American ally in April, a 33% decline from 6.1 billion pounds in March.It was the lowest amount of goods exported to the U.S. since 2022 and the most significant decline since records began in 1997.According to a Reuters report, the British Chambers of Commerce stated that the decline was partly due to manufacturers shipping extra goods in March to avoid a tariff increase. Even so, April's goods exports were down 15% compared to a year earlier."The economic effects of the U.S. tariffs are now a reality. Thousands of UK exporters are dealing with lower orders and higher supply chain and customer costs," the BCC's head of trade policy, William Bain, reportedly said.While U.S. exports to the UK also dropped nearly 8% to 4.7 billion pounds. However, the record plunge in outbound shipments from Britain helped the U.S. log its first trade surplus with the country since May 2024.The trade imbalance caused the UK gross domestic product (GDP) to contract by 0.3% in April, compared with the 0.1% expected by economists polled by Reuters.Washington, D.C., first imposed 25% tariffs on British steel and aluminum on March 12, boosted the auto imports tariff to 27.5%, and imposed a blanket tariff of 10% on all other goods.&nbsp;The<a href="https://stocktwits.com/symbol/EWU"> iShares MSCI United Kingdom ETF</a> (EWU) has risen 20% this year, compared with 2.4% gains of the <a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY).Also See: <a href="https://stocktwits.com/news-articles/markets/equity/air-india-crash-tarnishes-boeing-787-s-flawless-safety-record-morgan-stanley-expects-more-regulatory-heat/chlLxchRRGV">Air India Crash Tarnishes Boeing 787’s Flawless Safety Record — Morgan Stanley Expects More Regulatory Heat</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Container ship at the Port of Long Beach, Long Beach, California. (Photo by: Citizens of the Planet/Universal Images Group via Getty Images)

Trump Tariffs Cause Biggest Fall On Record Of UK Exports To US 

The British Chambers of Commerce stated that the decline was partly due to manufacturers shipping extra goods in March to avoid a tariff increase.

Barclays’ Emmanuel Cau sees limited upside for EU equities into summer

Investing.com -- Barclays strategist Emmanuel Cau sees limited upside for European equities as markets head into the summer months, due to elevated valuations, macro uncertainty, and seasonal risks.

China has reportedly taken exception to the trade deal the UK has negotiated with the U.S., arguing that the pact hurts its interests.Britain was the first country to clinch an agreement with the U.S., resulting in the removal of the tariffs imposed on steel and autos, even as the baseline 10% tariff stayed.The exemption on the sector-specific tariffs was given on the condition that the UK would work toward “promptly” meeting U.S. requirements on supply-chain security and the ownership of relevant production facilities.The Trump administration also reportedly clarified that China was the intended target.The agreement terms also specified that tariff relief for UK goods would depend on the outcome of the Section 232 investigations, which examined whether and how specific imports impact U.S. national security.&nbsp;A Financial Times <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ft.com/content/52f7be1c-e708-4b01-b486-7f189a52c842">report</a> on Tuesday said that Beijing has not been happy with the UK’s deal with the U.S., which envisages heavy protection for domestic steel and pharmaceutical industries.China’s Foreign Ministry reportedly said, “Co-operation between states should not be conducted against or to the detriment of the interests of third parties.”The Chinese stance puts the UK in a fix, given the latter’s intent to rebuild its relationship with the world’s second-largest economy.The UK is also one of the biggest export destinations for China-made electric vehicles (EVs) and plug-in hybrids, according to a South China Morning post <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.scmp.com/economy/china-economy/article/3309729/while-electric-vehicle-exports-uk-are-down-plug-hybrids-are-bucking-trend">report.</a> Citing Chinese Customs data, the report said plug-in exports to the UK surged about 600% year over year in the first quarter, although EV sales slid nearly 3%.Meanwhile, China and the U.S. announced a bilateral pact on Monday, putting on hold the bulk of the tariffs announced by either party since the Liberation Day tariffs were announced by the Trump administration in early April.A separate Guardian report <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.theguardian.com/world/2025/apr/16/china-to-snub-uk-energy-summit-amid-row-over-infrastructure-projects">said</a> China has decided to postpone a 60-country UK energy summit to be held next week amid differences of opinion over the latter’s involvement in the British infrastructure sector.The <a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY), an exchange-traded fund (ETF)</a> that tracks the S&amp;P 500 Index, is up about 0.43% for the year and the <a href="https://stocktwits.com/symbol/EWU">iShares MSCI United Kingdom ETF (EWU)</a> has gained over 13%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/microsoft-layoffs-show-commitment-to-profitable-growth-analyst/chiq1WnRbN5">Microsoft Layoffs Show ‘Commitment' To Profitable Growth Amid Surging AI Costs, Says Barclays: Retail In Wait-And-Watch Mode</a>

UK Prime Minister Keir Starmer and U.S. President Donald Trump shake hands at a joint press conference in the East Room at the White House on February 27, 2025 in Washington, DC. 

Beijing Decries UK-US Trade Pact, Alleges Damage To Chinese Interests

Britain was the first country to clinch an agreement with the U.S., resulting in the removal of the tariffs imposed on steel and auto even as the baseline 10% tariff stayed.

EWU
iShares MSCI United Kingdom ETF

Feed

News

Sentiment

Fundamentals

Info

Latest EWU News

EWUiShares MSCI United Kingdom ETF